Water Street’s Celerity Has US Nod For First Ready-to-Use Insulin for IV Infusion
Executive Summary
US strategic investor Water Street Healthcare Partners has announced that its Celerity Pharmaceuticals subsidiary has won US FDA approval for the first ready-to-use insulin for intravenous infusion.